Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

European Respiratory Journal

Volumn 46, Issue 1, 2015, Pages 61-79

  Jiménez Ruiz, Carlos A ^a   Andreas, Stefan ^b   Lewis, Keir E ^c   Tonnesen, Philip ^d   Van Schayck, C P ^e   Hajek, Peter ^f   Tonstad, Serena ^g   Dautzenberg, Bertrand ^h   Fletcher, Monica ⁱ   Masefield, Sarah ^j   Powell, Pippa ^j   Hering, Thomas ^k   Nardini, Stefano ^l   Tonia, Thomy ^m   Gratziou, Christina ⁿ  

^a Community of Madrid ^*  (Spain)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c PRINCE PHILIP HOSPITAL   (United Kingdom)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ EDUCATION FOR HEALTH   (United Kingdom)

^j European Lung Foundation   (United Kingdom)

^k Lungenarztpraxis Tegel   (Germany)

^l Ospedale Civile   (Italy)

^m UNIVERSITY OF BERN   (Switzerland)

ⁿ Evgenidion Hospital   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CIGARETTE SMOKE; CISPLATIN; ERLOTINIB; NICOTINE; NICOTINE GUM; NORTRIPTYLINE; PLACEBO; RIFAMPICIN; VARENICLINE;

ARTICLE; ASTHMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; COMORBIDITY; COUNSELING; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG CANCER; LUNG DISEASE; LUNG INFECTION; LUNG TUBERCULOSIS; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); NICOTINE REPLACEMENT THERAPY; NON SMALL CELL LUNG CANCER; PASSIVE SMOKING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SELF CONCEPT; SKIN TOXICITY; SMALL CELL LUNG CANCER; SMOKING; SMOKING CESSATION; SURGICAL WOUND; SYSTEMATIC REVIEW (TOPIC); TOBACCO DEPENDENCE; TREATMENT DURATION; ADVERSE EFFECTS; COMPLICATION; EUROPE; LUNG TUMOR; PREVALENCE; PROCEDURES; PSYCHOLOGY; TOBACCO USE DISORDER;

ASTHMA; COMORBIDITY; EUROPE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84937404002     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00092614     Document Type: Article

References (163)

1. Tønnessen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE-trial. Eur Respir 1999; 13: 238-246.
2. Tønnesen P, Carrozzi L, Fagerström KO, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J 2007; 29: 390-417.
3. SmokeHaz: a scientific review of the health hazards of smoking. www.europeanlung.org/en/projects-and-research/projects/smokehaz/home Date last accessed: December 13, 2014.
4. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
5. Miller A, Raskin J. The natural history of COPD: confirming and going beyond Fletcher and Peto. Eur Respir J 2014; 44: 280-283.
6. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
7. Kerstjens HA, Rijcken B, Schouten JP, et al. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997; 52: 820-827.
8. Gold DR, Wang X, Wypij D, et al. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996; 335: 931-937.
9. Sherrill DL, Lebowitz MD, Knudson RJ, et al. Smoking and symptom effects on the curves of lung function growth and decline. Am Rev Respir Dis 1991; 144: 17-22.
10. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
11. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239.
12. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2010. www.goldcopd.org Date last accessed: August 20, 2014. Date last updated: January, 2015.
13. Kohansal R, Martinez-Camblor P, Agustí A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180: 3-10.
14. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-390.
15. van Schayck OC, Haughney J, Aubier M, et al. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. Respir Med 2012; 106: 189-196.
16. Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364: 1093-1103.
17. Jiménez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119: 1365-1370.
18. Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006; 61: 1043-1047.
19. Jiménez-Ruiz CA, Miravitlles M, Sobradillo V, et al. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentrations in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res 2004; 6: 649-653.
20. Crowley TJ, Macdonald MJ, Walter MI. Behavioural anti-smoking trial in chronic obstructive pulmonary disease patients. Psychopharmacology 1995; 119: 193-204.
21. Wagena EJ, Arrindell WA, Wouters EF, et al. Are patients with COPD psychologically distressed? Eur Respir J 2005; 26: 242-248.
22. Postma DS, Siafakas NM, eds. Management of Chronic Obstructive Pulmonary Disease. ERS Monogr 1998; 7.
23. Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 2005; 100: 159-167.
24. Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer 2011; 119: 1420-1427.
25. Rollnick S, Mason P, Butler C, et al. Health Behaviour Change: A Guide for Practitioners. London, Churchill Livingstone, 1999.
26. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991; 86: 1119-1127.
27. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, World Health Organization, 1992.
28. Etter JF, Le Houezec J, Perneger TV. A self-administered questionnaire to measure addiction to cigarettes: the cigarette dependence scale. Neuropsychopharmacology 2003; 28: 359-370.
29. Vangeli E, Stapleton J, Smit ES, et al. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011; 106: 2110-2121.
30. Pomerleau OF, Fagerström KO, Marks J, et al. Development and validation of a self-rating scale for positive-and negative-reinforcement smoking: the Michigan Nicotine Reinforcement Questionnaire. Nicotine Tob Res 2003; 5: 711-718.
31. Snedecor S, Pomerleau CS, Pomerleau OF, et al. POS2-118 A confirmatory factor analysis and concurrent validation of the Michigan Nicotine Reinforcement Questionnaire. 12th annual meeting of the Society for Research on Nicotine and Tobacco, Orlando, FL. 2006. https://srnt.org/conferences/abstracts/pdfs/2006-Abstracts.pdf
32. Jimenez Ruiz CA, Cicero Guerrero AM, Mayayo Ulibarri ML, et al. Phenotypic features in COPD smokers attending a smoking cessation unit. Eur Respir J 2011; 38: p1562.
33. Fagerström KO. Time to first cigarette: the best single indicator of tobacco dependence? Monaldi Arch Chest Dis 2003; 59: 91-94.
34. Arrol B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: cross-sectional study. BMJ 2003; 327: 1144-1146.
35. Strassmann R, Bausch B, Spaar A, et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009; 34: 634-640.
36. Hoogendoorn M, Feenstra TL, Hoogenveen RT, et al. Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax 2010; 65: 711-718.
37. Thabane M; COPD Working Group. Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess 2012; 12: 1-50.
38. van der Meer RM, Wagena EJ, Ostelo RW, et al. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2003; 2: CD002999.
39. Andreas S, Batra A, Behr J, et al. Tabakentwöhnung bei COPD [Smoking cessation in patients with COPD]. Pneumologie 2014; 68: 237-258.
40. Kanner RE, Connett JE, Williams DE, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 1999; 106: 410-416.
41. Brandt CJ, Ellegaard H, Joensen MB, et al. Effects of diagnosis of "smoker's lung". Lancet 1997; 349: 253.
42. Kotz D, Huibers MJ, West RJ, et al. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD? Patient Educ Couns 2009; 76: 16-24.
43. Sundblad BM, Larsson K, Nathell L. Lung function testing influences the attitude toward smoking cessation. Nicotine Tob Res 2010; 12: 37-42.
44. Bize R, Burnand B, Mueller Y, et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2009; 2: CD004705.
45. Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336: 598-600.
46. Lacasse Y, LaForge J, Maltais F. Got a match? Home oxygen therapy in current smokers. Thorax 2006; 61: 374-375.
47. Tønnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest 2006; 130: 334-342.
48. Tashkin DP, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571-1575.
49. Wagena EJ, Knispchild PG, Huibers MJ, et al. Efficacy of bupropion and nortryptiline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005; 165: 2286-2292.
50. Van Schayck CP, Kaper J, Wagena EJ, et al. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. Addiction 2009; 104: 2110-2117.
51. Tashkin DP, Rennard S, Hays JT, et al. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest 2011; 139: 591-599.
52. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
53. Tønnesen P, Mikkelsen KL. Smoking cessation with four nicotine regimes in a lung clinic. Eur Respir J 2000; 16: 717-722.
54. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; 3: CD000146.
55. Sundblad BM, Larsson K, Nathell L. High rates of smoking abstinence in COPD patients: smoking cessation by hospitalization. Nicotine Tob Res 2008; 10: 883-890.
56. Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009; 338: b1024.
57. Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res 2007; 9: 631-646.
58. Kanner RE, Anthonisen NR, Connett JE, et al. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001; 164: 358-364.
59. Simmons MS, Connett JE, Nides NA, et al. Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study. Eur Respir J 2005; 25: 1011-1017.
60. Zierler-Brown SL, Kyle JA. Oral varenicline for smoking cessation. Ann Pharmacother 2007; 41: 95-99.
61. Jiménez-Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, et al. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine Tob Res 2012; 14: 1035-1039.
62. U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General, 2014. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. www.surgeongeneral.gov/library/reports/50-years-of-progress Date last accessed: August 20, 2014.
63. Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer 2012; 131: 1210-1219.
64. Sardari Nia P, Weyler J, Colpaert C, et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005; 47: 351-359.
65. Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a society of thoracic surgeons general thoracic surgery database study. Ann Thorac Surg 2009; 88: 362-370.
66. Møller AM, Villebro N, Pedersen T, et al. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002; 359: 114-117.
67. Mills E, Eyawo O, Lockhart I, et al. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011; 124: 144-154.
68. Schmidt-Hansen M, Page R, Hasler E. The effect of preoperative smoking cessation or preoperative pulmonary rehabilitation on outcomes after lung cancer surgery: a systematic review. Clin Lung Cancer 2013; 14: 96-102.
69. Duarte RL, Luiz RR, Paschoal ME. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients. Lung Cancer 2008; 61: 244-254.
70. Mohan A, Singh P, Kumar S, et al. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer. Asian Pac J Cancer Prev 2008; 9: 557-562.
71. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353: 123-132.
72. Hughes AN, O'Brien ME, Petty WJ, et al. Overcoming cyp1a1/1a2 mediated induction of metabolism by escalating erlotinib dose in current smokers. J Clin Oncol 2009; 27: 1220-1226.
73. van der Bol JM, Mathijssen RH, Loos WJ, et al. Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. J Clin Oncol 2007; 25: 2719-2726.
74. Couraud S, Zalcman G, Milleron B, et al. Lung cancer in never smokers-a review. Eur J Cancer 2012; 48: 1299-1311.
75. Lee YJ, Cho BC, Jee SH, et al. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol 2009; 28: 487-492.
76. An SJ, Chen ZH, Su J, et al. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. PLoS One 2012; 7: e40109.
77. Monson JM, Stark P, Reilly JJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998; 82: 842-850.
78. Sarihan S, Ercan I, Saran A, et al. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev 2005; 29: 181-188.
79. Fox JL, Rosenzweig KE, Ostroff JS. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer 2004; 44: 287-293.
80. Videtic GM, Stitt LW, Dar AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003; 21: 1544-1549.
81. Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569.
82. Chen J, Qi Y, Wampfler JA, et al. Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer 2012; 48: 1593-1601.
83. Balduyck B, Sardari Nia P, Cogen A, et al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg 2012; 40: 1432-1437.
84. Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004; 126: 1733-1741.
85. Taylor KL, Cox LS, Zincke N, et al. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer 2007; 56: 125-134.
86. van der Aalst CM, van den Bergh KA, Willemsen MC, et al. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010; 65: 600-605.
87. Cox LS, Africano NL, Tercyak KP, et al. Nicotine dependence treatment for patients with cancer. Cancer 2003; 98: 632-644.
88. Sanderson Cox L, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol 2002; 20: 3461-3469.
89. de Bruin-Visser JC, Ackerstaff AH, Rehorst H, et al. Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer. Eur Arch Otorhinolaryngol 2012; 269: 659-665.
90. Cooley ME, Wang Q, Johnson BE, et al. Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer. Lung Cancer 2012; 76: 144-149.
91. Cooley ME, Sarna L, Brown JK, et al. Tobacco use in women with lung cancer. Ann Behav Med 2007; 33: 242-250.
92. Schnoll RA, Malstrom M, James C, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns 2002; 46: 137-145.
93. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database System Rev 2004; 1: CD000031.
94. Park ER, Japuntich S, Temel J, et al. A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol 2011; 6: 1059-1065.
95. Wakefield M, Ruffin R, Campbell D, et al. Smoking-related beliefs and behaviour among adults with asthma in a representative population sample. Aust N Z J Med 1995; 25: 12-17.
96. Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol 2012; 158: 175-183.
97. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-1200.
98. Zheng X, Guan W, Zheng J, et al. Smoking influences response to inhaled corticosteroids in patients with asthma: a meta-analysis. Curr Med Res Opin 2012; 28: 1791-1798.
99. Boulet LP, FitzGerald JM, McIvor RA, et al. Influence of current or former smoking on asthma management and control. Can Respir J 2008; 15: 275-279.
100. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
101. Bush T, Zbikowski SM, Mahoney L, et al. State quitlines and cessation patterns among adults with selected chronic diseases in 15 states, 2005-2008. Prev Chronic Dis 2012; 9: E163.
102. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24: 822-833.
103. Van De Ven MO, van Zundert RM, Engels RC. Effects of asthma on nicotine dependence development and smoking cessation attempts in adolescence. J Asthma 2013; 50: 250-259.
104. Eisner MD, Yelin EH, Katz PP, et al. Predictors of cigarette smoking and smoking cessation among adults with asthma. Am J Public Health 2000; 90: 1307-1311.
105. Piccillo G, Caponnetto P, Barton S, et al. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med 2008; 102: 256-265.
106. Tønnesen P, Pisinger C, Hvidberg S, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7: 139-148.
107. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
108. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. May 2008, Revised January 2012. http://sign.ac.uk/guidelines/fulltext/101/Date last accessed: October 26, 2014.
109. Zumla A, George A, Sharma V, et al. WHO's 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet 2013; 382: 1765-1767.
110. Mackay J, Crofton J. Tobacco and the developing world. Br Med Bull 1996; 52: 206-221.
111. Thomas G. The consequences of smoking and tobacco on lung disease in developing countries: plenary lecture given during the 37th Union World Conference on Lung Health, Palais des Congres, Paris, France, 31 October-4 November 2006. Int J Tuberc Lung Dis 2007; 11: 1270-1271.
112. Brunet L, Pai M, Davids V, et al. High prevalence of smoking among patients with suspected tuberculosis in South Africa. Eur Respir J 2011; 38: 139-146.
113. Lam C, Martinson N, Hepp L, et al. Prevalence of tobacco smoking in adults with tuberculosis in South Africa. Int J Tuberc Lung Dis 2013; 17: 1354-1357.
114. Singh PN, Yel D, Kheam T, et al. Cigarette smoking and tuberculosis in Cambodia: findings from a national sample. Tob Induc Dis 2013; 11: 8.
115. Pradeepkumar AS, Thankappan KR, Nichter M. Smoking among tuberculosis patients in Kerala, India: proactive cessation efforts are urgently needed. Int J Tuberc Lung Dis 2008; 12: 1139-1145.
116. Dhamgaye TM. Tobacco smoking and pulmonary tuberculosis: a case-control study. J Indian Med Assoc 2008; 106: 216-219.
117. Gajalakshmi V, Peto R. Smoking, drinking and incident tuberculosis in rural India: population-based case-control study. Int J Epidemiol 2009; 38: 1018-1025.
118. Gambhir HS, Kaushik RM, Kaushik R, et al. Tobacco smoking-associated risk for tuberculosis: a case-control study. Int Health 2010; 2: 216-222.
119. Wang J, Shen H. Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients. BMC Public Health 2009; 9: 292.
120. Trifunovi? VS, Gvozdenovi? BS, Jovanovic D, et al. [Association between tobacco smoking and pulmonary tuberculosis]. Vojnosanit Pregl 2009; 66: 797-801.
121. Matsumoto K, Arima K, Komukai J, et al. [The association between smoking and sputum smear-positive pulmonary tuberculosis in Osaka City]. Kekkaku 2012; 87: 541-547.
122. Bonacci RA, Cruz-Hervert LP, Garcia-Garcia L, et al. Impact of cigarette smoking on rates and clinical prognosis of pulmonary tuberculosis in Southern Mexico. J Infect 2013; 66: 303-312.
123. Horne DJ, Campo M, Ortiz JR, et al. Association between smoking and latent tuberculosis in the U.S. population: an analysis of the National Health and Nutrition Examination Survey. PLoS One 2012; 7: e49050.
124. Maurya V, Vijayan VK, Shah A. Smoking and tuberculosis: an association overlooked. Int J Tuberc Lung Dis 2002; 6: 942-951.
125. Watkins RE, Plant AJ. Does smoking explain sex differences in the global tuberculosis epidemic? Epidemiol Infect 2006; 134: 333-339.
126. Davies PD, Yew WW, Ganguly D, et al. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006; 100: 291-298.
127. den Boon S, Verver S, Marais BJ, et al. Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics 2007; 119: 734-739.
128. Leung CC, Lam TH, Ho KS, et al. Passive smoking and tuberculosis. Arch Intern Med 2010; 170: 287-292.
129. Altet MN, Alcaide J, Plans P, et al. Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case-control study. Tuber Lung Dis 1996; 77: 537-544.
130. Visser ME, Stead MC, Walzl G, et al. Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype. PLoS One 2012; 7: e29588.
131. Fekih L, Boussoffara L, Abdelghaffar H, et al. Effet du tabagisme sur la tuberculose pulmonaire [Effect of tobacco smoking on pulmonary tuberculosis]. Rev Med Liege 2010; 65: 152-155.
132. Tachfouti N, Nejjari C, Benjelloun MC, et al. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Int J Tuberc Lung Dis 2011; 15: 838-843.
133. Gajalakshmi V, Peto R, Kanaka TS, et al. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003; 362: 507-515.
134. Jiang J, Liu B, Nasca PC, et al. Smoking and risk of death due to pulmonary tuberculosis: a case-control comparison in 103 population centers in China. Int J Tuberc Lung Dis 2009; 13: 1530-1535.
135. Wen CP, Chan TC, Chan HT, et al. The reduction of tuberculosis risks by smoking cessation. BMC Infect Dis 2010; 10: 156.
136. Jee SH, Golub JE, Jo J, et al. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170: 1478-1485.
137. Lin HH, Ezzati M, Chang HY, et al. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 2009; 180: 475-480.
138. Siddiqui UA, O'Toole M, Kabir Z, et al. Smoking prolongs the infectivity of patients with tuberculosis. Ir Med J 2010; 103: 278-280.
139. Lavigne M, Rocher I, Steensma C, et al. The impact of smoking on adherence to treatment for latent tuberculosis infection. BMC Public Health 2006; 6: 66.
140. PrayGod G, Range N, Faurholt-Jepsen D, et al. Sex, smoking, and socioeconomic status are associated with body composition among tuberculosis patients in a deuterium dilution cross-sectional study in Mwanza, Tanzania. J Nutr 2013; 143: 735-741.
141. Underner M, Perriot J. Tabac et tuberculose [Smoking and tuberculosis]. Presse Med 2012; 41: 1171-1180.
142. Xie ZY. [A study of blood rifampin concentration in smoking and non-smoking healthy individuals and in patients with tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 1989; 12: 3-5, 60.
143. Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax 2002; 57: 964-966.
144. Ng N, Padmawati RS, Prabandari YS, et al. Smoking behavior among former tuberculosis patients in Indonesia: intervention is needed. Int J Tuberc Lung Dis 2008; 12: 567-572.
145. Shin SS, Xiao D, Cao M, et al. Patient and doctor perspectives on incorporating smoking cessation into tuberculosis care in Beijing, China. Int J Tuberc Lung Dis 2012; 16: 126-131.
146. Amara B, El Ghazi K, Rahimi H, et al. Attitudes et connaissances des pneumo-phtisiologues marocains vis-a-vis du tabagisme chez leurs patients tuberculeux [Attitudes and knowledge about smoking among Moroccan physicians looking after patients with tuberculosis]. Rev Mal Respir 2008; 25: 569-575.
147. Sereno AB, Soares EC, Lapa ESJR, et al. Feasibility study of a smoking cessation intervention in Directly Observed Therapy Short-Course tuberculosis treatment clinics in Rio de Janeiro, Brazil. Rev Panam Salud Publica 2012; 32: 451-456.
148. Siddiqi K, Khan A, Ahmad M, et al. Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial. Ann Intern Med 2013; 158: 667-675.
149. Awaisu A, Haniki Nik Mohamed M, Noordin NM, et al. Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life. Tob Induc Dis 2012; 10: 2.
150. Enarson DA, Slama K, Chiang CY. Providing and monitoring quality service for smoking cessation in tuberculosis care. Int J Tuberc Lung Dis 2007; 11: 838-847.
151. Thompson DR, Chair SY, Chan SW, et al. Motivational interviewing: a useful approach to improving cardiovascular health? J Clin Nurs 2011; 20: 1236-1244.
152. Asfar T, Ebbert JO, Klesges RC, et al. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav 2011; 36: 764-768.
153. Bolliger C, Zellweger CP, Danielson T, et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res 2002; 4: 433-439.
154. Hughes JR, Solomon LJ, Livingston AE, et al. A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit. Drug Alcohol Depend 2010; 111: 105-113.
155. Hatsukami DK, Rennard S, Patel MK, et al. Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med 2004; 116: 151-157.
156. Hughes J, Rennard S, Fingar J, et al. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tobacco Res 2011; 13: 955-964.
157. Shiffman S, Ferguson SG. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction 2008; 103: 557-563.
158. Fiore MC, Baker TB. Clinical practice. Treating smokers in the health care setting. N Engl J Med 2011; 365: 1222-1231.
159. Lindson N, Aveyard P. An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology 2011; 214: 579-592.
160. Hajek P, McRobbie HJ, Myers KE, et al. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med 2011; 171: 770-777.
161. Koegelenberg CF, Noor F, Bateman ED, et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA 2014; 312: 155-161.
162. Hajek P, Smith KM, Dhanji AR, et al. Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial. BMC Med 2013; 11: 140.
163. Ebbert JO, Hatsukami DK, Croghan IT, et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA 2014; 311: 155-163.